#Pre-Filled Auto Injectors Market Size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Kazakhstan’s Minister of Communications and Informatics has blocked the Tumblr site because it contained 60 sites of terrorism, extremism, and pornography in 2015.
Text
#Pre-Filled Auto Injectors Market#Pre-Filled Auto Injectors Market share#Pre-Filled Auto Injectors Market size
0 notes
Text
Prefilled Syringes Market Demand Boosted By Advancements In Auto-Injectors And Reduced Prices Per Dose
The global prefilled syringes market size is anticipated to reach USD 50.83 billion by 2030, expanding at a CAGR of 11.95% from 2022 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.
The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. According to American Pharmaceutical Review in December 2021, COVID-19 vaccines are being created at an unprecedented rate in response to the worldwide pandemic. COVID-19 vaccination doses totaled 7.3 billion by November 9, 2021, with approximately 30.3 million doses provided daily.
Gain deeper insights on the market and receive your free copy with TOC now @: Prefilled Syringes Market Report
As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes. For instance, in March 2022, Schott announced further investments in its pharma sector, including expanding its capacity in Hungary for prefillable glass syringe production. The increased capacity is likely to benefit the global market and provide greater supply security for major pharmaceutical corporations and contract manufacturing firms. As a result, due to the outbreak of coronavirus infection in 2020, sales of prefilled syringes increased globally.
Furthermore, emergency syringes used to treat some of COVID-19's most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list. For instance, in October 2019, Premier Inc. teamed up with Amphastar Pharmaceuticals, Inc. to provide phytonadione injection and emergency, pre-filled syringes of sulphate, dextrose, sodium bicarbonate, epinephrine, atropine, calcium chloride, and lidocaine to healthcare practitioners through its ProvideGx programme. These characteristics are projected to generate lucrative market growth prospects.
#Prefilled Syringes Market Size & Share#Prefilled Syringes Market Latest Trends#Prefilled Syringes Market Growth Forecast#COVID-19 Impacts On Prefilled Syringes Market#Prefilled Syringes Market Revenue Value#Global Prefilled Syringes Market
0 notes
Photo
Pre-Filled Auto Injectors Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast
#Pre-Filled Auto Injectors Market Share#Pre-Filled Auto Injectors Market Size#Pre-Filled Auto Injectors Market Trend#Pre-Filled Auto Injectors Market
0 notes
Text
Injectable Drug Delivery Technology Market Dynamics, Emerging Trends and Growth Factors Forecast 2022-2030
Acumen Research and Consulting announced the latest market research report on "Global Injectable Drug Delivery Technology Market : Global Industry Size, Share, Trends and Forecast, 2018 - 2026”.
The global Injectable Drug Delivery Technology Market research report is inclusive of detailed and productive qualitative and quantitative information, for the historic period, base year, and the forecast period, which can benefit the user for taking the appropriate decision on the basis of market knowledge, as well as for gathering valuable information for further estimations. Download FREE SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.acumenresearchandconsulting.com/request-sample/859
The detailed information of the global Injectable Drug Delivery Technology Market about the driving factors, development strategies such as new product development, mergers and acquisition, and partnerships & collaboration, recent trends, as well as challenges and opportunities are incorporated for a more extensive understanding of the market potential.
Moreover, the global market is finely segmented and on the basis of geography segmented across North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East and Africa (GCC, South Africa, and Rest of Middle East & Africa). And the regions are further studied across the respective major countries including detailed current trends and available opportunities in the respective market. Segmentation
Market By Formulation
Nanoparticles Liposomes Microspheres Others
Market By Device Type
Needle Free Injectors Reusable Needles Pre-Filled Syringes Auto Injectors Pen Needle Disposable Syringes Others
Market By Mode Of Delivery
Intraperitoneal Intravenous Intramuscular Subcutaneous Others
Market By Application
Oncology Orphan Diseases Auto-Immune Disease Others
Global Injectable Drug Delivery Technology Market : Competitive Landscape
Along with this, the research report encompasses comprehensive information of market leaders that majorly include a business overview, financial overview, product offerings, strategic developments, and geographical presence. The profiled players are collaboratively analyzed for digging out the market scenarios in a more competitive manner.
Essentially, it’s a well-compiled solution for the industry players, managers, researchers, strategists, consultants, education organizations, students, and start-ups. They can get the required information in an easy and understandable format for the required task and will be able to interpret in almost no time and able to saves time. Moreover, in case of further customization or addition required in the report scope, our team is able to provide for meeting the expectations of users. Who are the key players in the market? The key players operating in Injectable Drug Delivery Technology Market such as Key Players:
The injectable drug delivery technology market comprises of some of the major players such as Alkermes Inc., Bend Research, Polymer Factory, Genentech Inc., MicroCHIPS, Inc., Presage Bioscience, QLT Inc., BIND Biosciences, Inc., Endocyte, Pearl Therapeutics Inc., and UCB Group. Overview of the Impact of COVID-19 on Injectable Drug Delivery Technology Market : The development of COVID-19 has carried the world to a stop. We comprehend that this health emergency has brought an unprecedented effect on businesses across ventures. However, this also will pass. Rising help from governments and a few organizations can help in the battle against this profoundly infectious sickness. There are a few industries that are battling and some are flourishing. In general, pretty much every segment is foreseen to be affected by the pandemic. We are making persistent efforts to enable your business to continue and develop during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across ventures to assist you to prepare for the future. In a nutshell, the global Injectable Drug Delivery Technology Market research report encompasses the desired information in terms of both quality and quantity with the respective market. The collection of information is completely based on the authorized sources and compiled by the experts and research analysts with years of experience in the respective industry vertical.
Inquiry Before Buy Report @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/859 Few Significant Points From Table Of Content:
CHAPTER 1.INDUSTRY OVERVIEW
Definition of Injectable Drug Delivery Technology
Market Segmentation
List of Abbreviations
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Formulations (2015-2026)
Global Injectable Drug Delivery Technology Market Revenue Share By Formulations in 2017
Nanoparticles
Liposomes
Microspheres
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Device Type (2015-2026)
Needle Free Injectors
Reusable Needles
Pre-Filled Syringes
Auto Injectors
Pen Needle
Disposable Syringes
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Mode Of Delivery (2015-2026)
Intraperitoneal
Intravenous
Intramuscular
Subcutaneous
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison By Application (2015-2026)
Oncology
Orphan Diseases
Auto-Immune Disease
Others
Global Injectable Drug Delivery Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
North America Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Europe Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Asia-Pacific Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Latin America Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
Middle East and Africa (MEA) Injectable Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
CHAPTER 2.MARKET DYNAMICS AND COMPETITION ANALYSIS
Market Drivers
Restraints and Challenges
Growth Opportunities
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitute
Threat of New Entrants
Degree of Competition
Value Chain Analysis
Raw Material and Suppliers
Manufacturing Process Analysis
Regulatory Compliance
Player Positioning Analysis
Key Strategies Adopted By Leading Players
CHAPTER 3.MANUFACTURING PLANTS ANALYSIS
Capacity and Commercial Production Date of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
Manufacturing Plants Distribution of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
R&D Status and Technology Source of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
Raw Materials Sources Analysis of Global Injectable Drug Delivery Technology Major Manufacturers in 2017
CHAPTER 4.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY FORMULATION
Global Injectable Drug Delivery Technology Revenue By Formulation
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY DEVICE TYPE
Global Injectable Drug Delivery Technology Revenue By Formulation
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY MODE OF DELIVERY
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7.INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY APPLICATION
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8.NORTH AMERICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
North America Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
North America Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
U.S. Injectable Drug Delivery Technology Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9.EUROPE INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Europe Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Europe Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10.ASIA-PACIFIC INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Asia-Pacific Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Asia-Pacific Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11.LATIN AMERICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Latin America Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Latin America Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 12.MIDDLE EAST INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Middle East Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Middle East Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 13.AFRICA INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
Africa Injectable Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
Africa Injectable Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
Market Revenue and Forecast By Formulation, 2015 - 2026 ($Million)
Market Revenue and Forecast By Device Type, 2015 - 2026 ($Million)
Market Revenue and Forecast By Mode Of Delivery, 2015 - 2026 ($Million)
Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 14.COMPANY PROFILE
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
Company Snapshot
Overview
Financial Overview
Type Portfolio
Key Developments
Strategies
CHAPTER 15.RESEARCH APPROACH
Initial Data Search
Secondary Research
Primary Research
Assumptions and Scope
Customized Requirements? Inquiry Before Buying? Please Email us at [email protected] | Single User License US$ 4500
The Final Report will cover the impact analysis of COVID-19, Download Full Study Report (Single User License US$ 4500)@ https://www.acumenresearchandconsulting.com/buy-now/0/859 Key Questions Answered in the Report The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include- - What is the overall structure of the market? - What was the historical value and what is the forecasted value of the market? - What are the key product level trends in the market? - What are the market level trends in the market? - Which of the market players are leading and what are their key differential strategies to retain their stronghold? - Which are the most lucrative regions in the market space? The report is readily available and can be dispatched immediately after payment confirmation.
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 20 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country-level expertise.
For more information, please contact:
Frank Wilson
Acumen Research And Consulting Email: [email protected] Tel: +14079154157
Related Links https://www.acumenresearchandconsulting.com/
0 notes
Text
Injectable Drug Delivery Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2030
The report studies the historical data of the Injectable Drug Delivery Market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the Injectable Drug Delivery Market based on the recent technological and research advancements.
The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to latest analysis by Emergen Research. Injectable drug delivery market revenue growth is owing to a rising trend of pre-filled syringes along with technological developments. Initially, medication was only available in the form of tablets, pills, or capsules; however, medicines are now given via more technologically advanced and intelligent methods. These systems are meant to deliver medications to a specific location, allowing them to be more localized than would be possible through the circulatory system.
Advanced injectable devices are preferred by patients who take medications daily over standard injection devices. As a result, growing demand for effective and convenient drug delivery systems gives manufacturers a potential growth opportunity to develop advanced, user-friendly, and effective drug delivery devices. Increasing frequency of chronic illnesses and other life-threatening disorders highlights the need for new and effective medications across a wide range of treatment areas.
Get a sample of the report @ https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market
Regional Analysis - The research report is an investigative study providing a conclusive view of the Injectable Drug Delivery business sphere by an in-depth segmentation of the market into key applications, types, and regions. These segments are analysed on the basis of present, emerging, and future trends. The regional segmentation provides current and forecast demand estimation for the Injectable Drug Delivery industry in key regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Some major companies in global market report include Vetter Pharma, Akorn Operating Company LLC, Catalent, Inc., Pfizer Inc., Gerresheimer AG, Elcam Medical, Schott, SHL Medical AG, Becton, Dickinson & Company, and West Pharmaceutical Services, Inc.
Key questions addressed in the report:
What are the key factors driving the global Injectable Drug Delivery market?
Who are the key manufacturers in this market space?
Who are the distributors, traders and dealers of this market?
What are the market opportunities and risks affecting the performance of the vendors in the global Injectable Drug Delivery market?
What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?
Emergen Research has segmented global injectable drug delivery market on the basis of device type, product type, end-use, and region:
Device Type Outlook (Revenue, USD Billion; 2019-2030)
Product Type Outlook (Revenue, USD Billion; 2019-2030)
End-use Outlook (Revenue, USD Billion; 2019-2030)
Conventional Injectables
Pre-Filled Syringes
Auto-Injectors
Pen-Injectors
Freeze-Dried Products
Injectable Sterile Products
Hospitals
Homecare Settings
Clinics
Others
Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Take a Look at our Related Reports:
Industry 4.0 Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/industry-4-market
Big Data Analytics in Manufacturing Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/big-data-analytics-in-manufacturing-market
Next-Generation Biomanufacturing Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/next-generation-biomanufacturing-market
Deep Learning Chip
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/deep-learning-chip-market
Vehicle-to-Everything (V2X)
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/vehicle-to-everything-market
Big Data Analytics in BFSI
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/big-data-analytics-in-bfsi-market
Structured Cabling Market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/structured-cabling-market
Deep Learning System
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/deep-learning-system-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
0 notes
Text
Prefilled Syringes Market To Surge Beyond $22.5 Billion By 2025
The global prefilled syringes market size is expected to reach a value of USD 22.5 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.2% during the forecast years. Growing usage of prefilled syringes and technological advancements in auto-injectors are the key factors driving the market. Prefilled syringes are rapidly replacing traditional syringe-vial combinations due to advantages offered by them, such as increased patient safety and convenience for healthcare practitioners in dose preparation and delivery.
These syringes enable easy management of chronic diseases, such as diabetes and rheumatoid arthritis, which is expected to boost the usage of autoinjectors and pen injectors during the forecast period. Thus, the growing prevalence of diabetes and other chronic diseases would fuel the market demand over the next few years. The introduction of advanced devices with Wi-Fi and Bluetooth connectivity facilitating effective management of patient health records is also expected to boost the product demand.
The application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and other biotech drugs, which otherwise tend to become unstable and react with the material of the container resulting in altered drug potency. Rising preference for biotechnology drugs and the emerging biotech sector presenting greater opportunities are expected to have a positive impact on market development during the forecast period.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from the study suggest:
Currently, the use of glass prefilled syringes is greater than plastic syringes owing to high demand from healthcare professionals. Glass prefilled syringes are easy to use and lower the risks at the time of injection
However, the plastic syringes are rapidly replacing glass syringes due to the advent of advanced, biocompatible materials, such as Polypropylene (PP) and crystal clear polymer
Europe was the dominant regional market for prefilled syringes in 2015. High adoption of patient safety measures and the presence of key companies are the factors responsible for its the region’s growth
On the other hand, North America is expected to witness the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region
Major companies in the global market are Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation, Owen Mumford Ltd., Schott Group, Datwyler Pharma Packaging, and Becton, Dickinson and Company
The market for prefilled syringe manufacturing is consolidated; however, new companies are bringing innovative technologies to this field, which can be used for the manufacturing of auto-injectors.
Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and region:
Prefilled Syringes Type Outlook (Revenue, USD Million, 2014 - 2025)
Disposable
Reusable
Prefilled Syringes Material Outlook (Revenue, USD Million, 2014 - 2025)
Glass
Plastic
Prefilled Syringes Application Outlook (Revenue, USD Million, 2014 - 2025)
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others
Vaccines and Other Biotech Drugs
Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers
Prefilled Syringes Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
Europe
Asia Pacific
Latin America
MEA
The U.S.
Canada
The U.K.
Germany
Japan
India
Brazil
Mexico
South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Autoimmune Disorders Drug Delivery Devices Market by Product (Pre-filled Syringes, Pen Injectors, Vials, Auto-Injectors, Others); by Indications (Psoriasis, Multiple Sclerosis, Inflammatory Bowel Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Others); by End-Users (Hospitals & Clinics, Home Care Settings) and by Region (North America, Europe, Asia Pacific, Latin America, MEA); - Global Forecasts 2021 to 2027
#Autoimmune Disorders Drug Delivery Devices Market#Autoimmune Disorders Drug Delivery Devices Industry#AllTheResearch
0 notes
Text
Injectable Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Global Analysis | Precise Market Intelligence Report
Click for Full Report: https://www.precisemarketintelligence.com/report/8/injectable-drug-delivery-market
The medications are delivered using injectable route of administration. This route is convenient and offers greater bioavailability as compared to oral route of administration. There are technological advancements in devices used for injection of medicines. These modifications allow patients to take the medications daily using injectable route of administration. The new products such as auto-injectors, pre-filled syringes, pen-injectors, etc. are proving to be ground breaking technologies in this segment. These advancements are boosting the growth rate of the market over the conventional injectables.
The global Injectable Drug Delivery market size was estimated to be at USD XXX million in 2019, and is expected to grow at a CAGR of XX% during forecast period to reach USD XXX million in 2027.
Market Dynamics:
Increasing new product launches, increasing patient population suffering from chronic diseases, research and development for the introduction of novel products to minimize the unmet medical needs, technological advancements, etc. are some of the factors that are fueling the growth of the market. Product recalls and stringent regulations may hinder the growth of the market during forecast period. The increased use of injectables for medications without skilled professionals is creating opportunity for manufacturers to focus on introducing such products.
#Injectable Drug Delivery#Injectable Drug Delivery Market#Injectable Drug Delivery Market Dynamics#Injectable Drug Delivery Market Develo
0 notes
Text
By 2026, Injectable Drug Delivery Market To Surpass US$ 32.5 - Coherent Market Insights
From 2018 – 2026, The global injectable drug delivery market is expected to exhibit a CAGR of 8.3%
Request for Sample PDF Copy:
https://www.coherentmarketinsights.com/insight/request-pdf/2768
Description:
Injectable drug delivery is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action.
The global injectable drug delivery market size was valued at US$ 15,939.0 million in 2017, and is expected to exhibit a CAGR of 8.3% over the forecast period (2018 – 2026).
Figure 1. Global Injectable Drug Delivery Market Value (US$ Mn), by Region, 2017
Injectable Drug Delivery | Coherent Market Insights
Increasing prevalence of chronic diseases such as diabetes and anaphylaxis is expected to propel growth of the global injectable drug delivery market
Increasing prevalence of chronic diseases such as diabetes and other diseases is expected to drive the market growth. According to the World Health Organization (WHO), in November 2011, around 60 million people in Europe suffered from diabetes, of which around 10.3% were men and 9.6% were women aged 25 years and above. Similarly, according to World Health Organization (WHO) 2018 factsheet, around 8.5% adults aged 18 years and above had diabetes in 2014 globally.
Moreover, the market players are focused on product development and launch of injectors, which is expected to propel growth of the global injectable drug delivery market over the forecast period. For instance, in 2016, Berlin-Chemie launched BerliPen areo 3 in Germany. BerliPen areo 3 is a 300 unit insulin pen, which can be used with six different insulins in the treatment of type 1 and 2 diabetes. Similarly, in August 2018, Teva Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for generic version of Mylan’s EpiPen and EpiPen Jr. Teva Pharmaceuticals is the first generic manufacturer that received the FDA approval.
However, increasing product recalls is expected to hinder the market growth. In December 2012, Bracco Diagnostics Inc., initiated a Class I recall of nine lots of Isovue Pre-Filled Power Injector Syringes, which are to be used with Stellant CT Injection Systems, due to presence of visible particles in syringes observed at the end of standard stability studies on retained samples, according to the U.S. Food and Drug Administration (FDA)
Figure 2. Global Injectable Drug Delivery Market Share (%), by Usability,2018 and 20 Injectable Drug Delivery | Coherent Market Insights
Source: Coherent Market Insights Analysis (2019)
Increasing product approval and launch in North America is expected to bolster the market growth
North America holds dominant position in the global injectable drug delivery market, owing to increased focus of regional players in research and development and product launches. In 2017, Bayer received U.S. Food and Drug Administration (FDA) approval for a connected auto-injector-BETACONNECT for relapsing-remitting multiple sclerosis medication and companion app- myBETAapp. The app allows patients to automatically have a record of all their injections and share that record with their nurse or physician. Similarly, in October 2018, Genentech announced the U.S. Food and Drug Administration (FDA) approval for single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an additional formulation for both allergic asthma and chronic idiopathic urticaria (CIU) indications.
Moreover, increasing incidence of chronic diseases such as anaphylaxis, diabetes, and cardiac arrest in the region is expected to support growth of the market during the forecast period. For instance, according to Journal of Allergy and Clinical Immunology, 2014, prevalence of anaphylaxis in the U.S. was 1.6% in the general population, while the number of hospitalizations associated with the disease is ever increasing in the U.S.
Furthermore, increasing initiatives by companies to make auto-injectors available to patients suffering from anaphylaxis is expected to boost global injectable drug delivery market. For instance, Mylan N.V. provides discount cards to epinephrine buyers, and offers discounts up to US$ 300 on branded version of EpiPen and up to US$ 25 on the approved generic version of EpiPen.
Key Players
Major players operating in the global injectable drug delivery market include Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, and Injex Pharma GmbH
About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.
Buy Report Here:
https://www.coherentmarketinsights.com/insight/buy-now/2768
Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave. #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
0 notes
Text
Self-Injection Devices Market 2022 | Cancer Segment Anticipated To Gain Highest Industry Share
The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.
Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.
Gain deeper insights on the market and receive your free copy with TOC now @: Self-injection Devices Market Report
Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.
The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.
#Self-injection Devices Market Size & Share#Self-injection Devices Market Latest Trends#Self-injection Devices Market Growth Forecast#COVID-19 Impacts On Self-injection Devices Market#Self-injection Devices Market Revenue Value#Global Self-injection Devices Market
0 notes
Text
Asia Pacific (APAC) Drug Delivery Devices Market - Trends and Forecast to 2024
Asia Pacific Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) – Industry Trends and Forecast to 2024
APAC Drug Delivery Devices Market is expected to reach USD 235.8 billion by 2024 from USD 130.9 billion in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.
Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-apac-drug-delivery-devices-market
· On the basis of route of administration the APAC drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
· The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups.
· �� The Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
· The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. Based on the route of administration, oral drug delivery market dominates the market in 2015 and in the near future injectable drug delivery market will dominate the APAC drug delivery devices market with the largest share in the drug delivery market. Topical drug delivery market is considered to be the fastest growing market with the CAGR of 11.5%.
Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-apac-drug-delivery-devices-market
The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
Nasal drug delivery devices are segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sunlingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the APAC drug delivery devices market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the North America drug delivery devices market.
The major factors contributing to the growth of the APAC drug delivery devices market are rising prevalence of chronic diseases, growing geriatric population, increase in diagnosis, growth of biosimilars, new product launches, drug innovation, technological advancements, and decrease in the level of pain. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.
Compotator
The major players covered in the report are Alcoa Corporation, Endurance Technologies Limited, Ryobi Limited, DyCast Specialties Corporation, Consolidated Metco, Inc., Alcast Technologies, Ningbo Beilun Create Mould Machine Co., Ltd, Leggett & Platt, Incorporated, Martinrea Honsel Germany GmbH, Gibbs, Dynacast, Reliance Foundry Co. Ltd., Toyota Industries Corporation, LA Aluminum, TPi Arcade, Drahtwerk Elisental W. Erdmann GmbH & Co., Wagstaff Inc., Ningbo Innovaw Mechanical CO.,LTD., Modern Aluminum Castings CO., INC. and Pacific Die Casting Corp.
Request for Toc@https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-apac-drug-delivery-devices-market
Global Asia Pacific (APAC) Drug Delivery Devices Market Size, Status and Forecast 2018 – 2025
1 Market Overview
2 Manufacturers Profiles
3 Global APAC Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer
4 Global APAC Cancer Diagnostics Market Analysis by Regions
5 North America Global APAC Cancer Diagnostics by Countries
6 Europe Global Asia Pacific (APAC) Drug Delivery Devices by Countries
7 Asia-Pacific Asia Pacific (APAC) Drug Delivery Devices by Countries
8 South America Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
9 Middle East and Africa Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
10 APAC Cancer Diagnostics Market Segment by Type
11 Global Asia Pacific (APAC) Drug Delivery Devices Market Segment by Application
12 Global APAC Cancer Diagnostics Market Forecast
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendixes
Based on geography the market is segmented into 7 countries, China, India, Japan, South Korea, Singapore, Australia and rest of APAC. Japan is expected to dominate the market, while China and India are expected to be the growing with highest CAGR in the forecast period.
The report also includes company share analysis for the major companies operating in this market by countries. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report. Some of the players in the market Bayer AG, Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, and 3M.
Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-apac-drug-delivery-devices-market
Reasons to Purchase this Report
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
· Amyotrophic Lateral Sclerosis (ALS) Market
· Antifungal Drugs Market
· Cutaneous Lupus Erythematosus Market
0 notes
Link
Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients.
#Pre-Filled Auto Injectors Market Share#Pre-Filled Auto Injectors Market Analysis#Pre-Filled Auto Injectors Market Trends#Pre-Filled Auto Injectors Market Growth
0 notes
Text
Prefilled Syringes Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
As per the recent study by FutureWise on prefilled syringes, the global market is predicted to value over US$ 10 Bn by the end of the assessment year 2026. Prefilled syringes are utilised to package a variety of medications and drugs, such as vaccines, therapeutic proteins and insulin. In recent years, prefilled syringes have gained colossal demand as it is affordable, accurate, convenient and safe. Healthcare specialists benefit from precise, pre-measured dosages, elimination of medication and dosage errors, and reduced risk of microbial contamination.
Despite holding multiple benefits, factors such as high manufacturing cost of prefilled syringes, storage difficulties, and stringent norms set by government authorities may hinder the growth of the market. Nonetheless, manufacturers should focus on technological improvements and innovations, and catering to the unmet demand for specific syringes as these are the key market growth aspects.
Increase in Prevalence of Chronic Diseases Globally to Augment the Growth of Prefilled Auto Syringes Market
Owing to the rising incidences of chronic diseases globally, healthcare professionals are exploring seeking alternate methods for patient care. As per the Centres for Disease Control and Prevention in 2014, approximately 29.1 million people in the United States were suffering from diabetes, which is 9.3% of the total population. Patients suffering from Type 1 diabetes are advised to undergo periodic intravenous administration of insulin to control their sugar levels inefficiency in natural insulin production. Prefilled syringes assist in self-administration of these drugs by making the treatment affordable, feasible and precise. Due to the rising incidents of chronic diseases in North America, the market displays notable growth.
APEJ region is poised to exhibit growing inclination towards injectable drug delivery systems. The growing ageing population in countries such as India and China, and increasing initiatives in the pharmaceutical industry, is surging the demand for prefilled syringes to treat diabetes and other autoimmune diseases.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=11&page=requestsample
Further Significant Highlights:
Glass prefilled syringes are forecasted to account for the largest market share. The growth of this segment can be associated with the soaring use of glass in manufacturing syringes due to its resistance towards chemical and heat, and nonreactive nature.
Single-chamber prefilled syringes are poised to dominate the market owing to the growing adoption of self-administered parenteral drugs
The market for prefilled syringe manufacturing is concentrated; nevertheless, innovative technologies in packaging material contributed by new players can be adapted to manufacture auto-injectors
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=94&page=askfordiscount
Vital Questions Answered
How rapidly will the prefilled syringes market grow globally?
What are the key factors influencing or restraining the growth of the market?
Key regions to focus on?
Investigating several aspects of the market with the help of Porter’s five forces analysis
Recognising the latest advancements, market shares, and strategies applied by the significant market players
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4. Global Pre-Filled Syringes Market Overview
4.1. Global Pre-Filled Syringes Market Revenue (USD Mn)
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Pre-Filled Syringes
6. Competition Dynamics
6.1. Company Share Analysis (2018)
6.2. Top 10 Product Pricing by Region
7. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Product Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
7.4.1 Single Chamber Pre-filled Syringe
7.4.2 Dual Chamber Pre-filled Syringe
8. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Material
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
8.4.1 Glass
8.4.2 Plastic
9. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by End User
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
9.4.1 Retail Pharmacies
9.4.2 Institutional Distribution
9.4.3 Online Pharmacies
10. Global Pre-Filled Syringes Market Revenue (USD Mn), 2018-2026 by Region
10.1.Key Market Findings
10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
11.5.3 Single Chamber Pre-filled Syringe
11.5.4 Dual Chamber Pre-filled Syringe
11.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
11.6.5 Glass
11.6.6 Plastic
11.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
11.7.7 Retail Pharmacies
11.7.8 Institutional Distribution
11.7.9 Online Pharmacies
12. Latin America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
12.5.5 Single Chamber Pre-filled Syringe
12.5.6 Dual Chamber Pre-filled Syringe
12.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
12.6.7 Glass
12.6.8 Plastic
12.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
12.7.9 Retail Pharmacies
12.7.10 Institutional Distribution
12.7.11Online Pharmacies
13. Europe America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
13.4.1 Germany
13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
13.5.8 Single Chamber Pre-filled Syringe
13.5.9 Dual Chamber Pre-filled Syringe
13.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
13.6.10 Glass
13.6.11 Plastic
13.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
13.7.12 Retail Pharmacies
13.7.13 Institutional Distribution
13.7.14 Online Pharmacies
14. Asia Pacific America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
14.4.1 Emerging Asia
14.4.1.1 China
14.4.1.2 India
14.4.1.3 ASEAN-5
14.4.1.4 Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
14.5.3 Single Chamber Pre-filled Syringe
14.5.4 Dual Chamber Pre-filled Syringe
14.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
14.6.5 Glass
14.6.6 Plastic
14.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
14.7.7 Retail Pharmacies
14.7.8 Institutional Distribution
14.7.9 Online Pharmacies
15. Rest of World America Pre-Filled Syringes Market Revenue (US$ Mn), 2018-2026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
15.5.5 Single Chamber Pre-filled Syringe
15.5.6 Dual Chamber Pre-filled Syringe
15.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026
15.6.7 Glass
15.6.8 Plastic
15.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
15.7.9 Retail Pharmacies
15.7.10 Institutional Distribution
15.7.11 Online Pharmacies
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2018
16.3. Company Profiles
16.3.1 Mylan N.V.
16.3.1.1 Corporate Overview
16.3.1.2 Financial Performance
16.3.1.3 Peer Comparison & 3C marketing equation
16.3.1.4 Company Strategy & Channel Management
16.3.2 Amedra Pharmaceuticals LLC
16.3.2.1 Corporate Overview
16.3.2.2 Financial Performance
16.3.2.3 Peer Comparison & 3C marketing equation
16.3.2.4 Company Strategy & Channel Management
16.3.3 Owen Mumford
16.3.3.1 Corporate Overview
16.3.3.2 Financial Performance
16.3.3.3 Peer Comparison & 3C marketing equation
16.3.3.4 Company Strategy & Channel Management
16.3.4 Ypsomed AG
16.3.4.1 Corporate Overview
16.3.4.2 Financial Performance
16.3.4.3 Peer Comparison & 3C marketing equation
16.3.4.4 Company Strategy & Channel Management
16.3.5 Antares Pharma
16.3.5.1 Corporate Overview
16.3.5.2 Financial Performance
16.3.5.3 Peer Comparison & 3C marketing equation
16.3.5.4 Company Strategy & Channel Management
16.3.6 SHL Group
16.3.6.1 Corporate Overview
16.3.6.2 Financial Performance
16.3.6.3 Peer Comparison & 3C marketing equation
16.3.6.4 Company Strategy & Channel Management
16.3.7 Johnson & Johnson
16.3.7.1 Corporate Overview
16.3.7.2 Financial Performance
16.3.7.3 Peer Comparison & 3C marketing equation
17. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
#Prefilled Syringes Market Share#Prefilled Syringes Market Size#Prefilled Syringes Market Trend#Prefilled Syringes Market Forecast#Prefilled Syringes Market
0 notes
Text
Prefilled Syringes Market Is Estimated To Expand At A CAGR of 11.2% During The Forecast Years
The global Prefilled Syringes Market size is expected to reach a value of USD 22.5 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.2% during the forecast years. Growing usage of prefilled syringes and technological advancements in auto-injectors are the key factors driving the market. Prefilled syringes are rapidly replacing traditional syringe-vial combinations due to advantages offered by them, such as increased patient safety and convenience for healthcare practitioners in dose preparation and delivery.
These syringes enable easy management of chronic diseases, such as diabetes and rheumatoid arthritis, which is expected to boost the usage of autoinjectors and pen injectors during the forecast period. Thus, growing prevalence of diabetes and other chronic diseases would fuel the market demand over the next few years. The introduction of advanced devices with Wi-Fi and Bluetooth connectivity facilitating effective management of patient health records is also expected to boost the product demand.
Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and other biotech drugs, which otherwise tend to become unstable and react with the material of the container resulting in altered drug potency. Rising preference for biotechnology drugs and emerging biotech sector presenting greater opportunities are expected to have a positive impact on the market development during the forecast period. To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from the study suggest:
Currently, the use of glass prefilled syringes is greater than plastic syringes owing to high demand from healthcare professionals. Glass prefilled syringes are easy to use and lower the risks at the time of injection
However, the plastic syringes are rapidly replacing glass syringes due to the advent of advanced, biocompatible materials, such as Polypropylene (PP) and crystal clear polymer
Europe was the dominant regional market for prefilled syringes in 2015. High adoption of patient safety measures and presence of key companies are the factors responsible for its the region’s growth
On the other hand, North America is expected to witness the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region
Major companies in the global market are Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation, Owen Mumford Ltd., Schott Group, Datwyler Pharma Packaging, and Becton, Dickinson and Company
The market for prefilled syringe manufacturing is consolidated; however, new companies are bringing innovative technologies to this field, which can be used for the manufacturing of auto-injectors.
Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and region:
Prefilled Syringes Type Outlook (Revenue, USD Million, 2014–2025)
Disposable
Reusable
Prefilled Syringes Material Outlook (Revenue, USD Million, 2014–2025)
Glass
Plastic
Prefilled Syringes Application Outlook (Revenue, USD Million, 2014–2025)
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others
Vaccines and Other Biotech Drugs
Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million, 2014–2025)
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers
Prefilled Syringes Regional Outlook (Revenue, USD Million, 2014–2025)
North America
US.
Canada
Europe
UK.
Germany
Asia Pacific
Japan
India
Latin America
Brazil
Mexico
MEA
South Africa
Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-prefilled-syringes-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com
0 notes
Text
Pre Filled Syringes Market | Forecast 2018 to 2024
Pre Filled Syringes Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Prefilled syringes market report gives a comprehensive outlook on prefilled syringes across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on prefilled syringes market gives historical, current, and future market sizes (US$ Mn) on the basis of material type, prefilled syringes type, design, end user, and geographic regions. This report studies prefilled syringes market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, prefilled syringes market report includes new product introduction, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed prefilled syringes market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the prefilled syringes market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of prefilled syringes.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-4H8Z4LpNMLEuOnnx
The global prefilled syringes market has been segmented based on material, design, drug class, application, and geography
Based on material, the global prefilled syringes market is segmented as:
· Glass
· Plastic
Based on design, the global prefilled syringes market is segmented as:
· Single Chamber
· Dual Chamber
· Customized
Based on drug class, the global prefilled syringes market is segmented as:
· Biologics
· Biosimilars
· Vaccines
· Others ( Anticoagulants, Antirheumatics)
Based on the application, the global prefilled syringes market is segmented as:
· Rheumatoid Arthritis
· Anaphylaxis
· Diabetes
· Others ( Cancer, Multiple Sclerosis)
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-c654SbFYO64MsOhu
Prefilled syringes are procuring the acceptance in market as a drug delivery systems which is designed for the injectable drugs. Prefilled syringes are generally preferred to the parenteral administration of the drugs and can be used mainly in treating chronic diseases where patients have to self-administer their medication, many times a week. Self-injecting devices consist of precise volumes of dose and already reconstituted drugs, which are helping in the elimination of the errors concerning dosage volumes and wastage of the drugs. Coping with the trend, most of the pharma companies are focusing to bring advancements in the therapies of self-administration. For example, EpiPen auto-injector and in the same way in July 2016, Bristol-Myers Squibb launched ORENCIA Clickject auto-injector commercially.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-14mlyhjMGhVjZqa3
Based on the geographical regions, the global Prefilled syringes market is segmented into five key regions, Asia-Pacific, Europe, North America, Latin America and Middle East & Africa Europe is the leading market for the prefilled syringes in terms of both volume and revenue. Asia pacific region is expected to show significant growth. Though the prefilled syringes market is in infant stage in APAC, factors like rising economic conditions, increase in purchasing power of people, rise in growth of awareness about the advantages of prefilled syringes, and the presence of large patients suffering with various chronic diseases are anticipated to drive the market. Japan accounts the major share of market in the Asia-Pacific market can be attributed to the increase in demand for self-administered treatments and high penetration of self-injection devices, rise in aging population, and increase in the prevalence of diabetes.
Some of the players in the global prefilled syringes market include SCHOTT AG (Germany), Gerresheimer (Germany), Medtronic (U.S.), Unilife Corporation (U.S.), Baxter International, Becton Dickinson & Co. (U.S.), Terumo Corporation (Japan), Stevanato Group (Italy), Vetter International (Ireland), and West Pharmaceuticals(U.S.)
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
0 notes
Text
Prefilled Syringes Market Size To Reach $22.5 Billion By 2025
The global prefilled syringes market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.
Prefilled injecting devices are rapidly replacing traditional syringe-vial combinations due to certain associated advantages such as increased patient safety and convenience offered to healthcare practitioners in dose preparation. Growing trend of self-injecting devices adopted for the management of chronic diseases, such as diabetes and rheumatoid arthritis, are expected to boost the growth of auto injectors and pen injectors during the forecast period. Growing prevalence of these diseases and introduction of advanced devices with Wi-Fi and Bluetooth connectivity that facilitate effective management of patient health records are factors expected to boost the usage of such devices.
Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and biotech drugs, which otherwise tend to become unstable and react with the material of the container that result in altered drug potency. Growing preference toward biotechnology drugs and the emerging biotech space presenting greater opportunities are expected to have a positive impact on the growth of the prefilled syringes market during the forecast period.
To request a sample copy or view summary of this report: https://www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from the study suggest:
The use of glass syringes to be high owing to their increasing preference amongst healthcare professionals; this is attributable to their ease of use and the low risk posed by these devices at the time of injection.
However, the plastic segmentis rapidly replacing the former with the introduction of advanced plastic materials, such as polypropylene and crystal clear polymer, which are biocompatible as glass.
Europe dominated the prefilled syringes space in 2015. High adoption of patient safety measures and presence of large number of market players are the factors responsible for the dominance of the region.
North America region is expected to show the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region.
The market is presently dominated by few key participants such as Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation,Owen Mumford, SCHOTT, Datwyler Pharma Packaging, and Becton, Dickinson and Company.
The syringe manufacturing market is consolidated; however, various new players are bringing innovative technologies to this sphere,which can be used for the manufacturing of auto-injectors.
Access Press Release Of This Research Report by Grand View Research: https://www.grandviewresearch.com/press-release/global-prefilled-syringes-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
0 notes